Magnetic sphincter augmentation: considerations for use in Barrett's esophagus

Audra J. Reiter, Domenico A. Farina, Jeffrey S. Fronza, Srinadh Komanduri*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Barrett's esophagus (BE) occurs in 5-15% of patients with gastroesophageal reflux disease (GERD). While acid suppressive therapy is a critical component of BE management to minimize the risk of progression to esophageal adenocarcinoma, surgical control of mechanical reflux is sometimes necessary. Magnetic sphincter augmentation (MSA) is an increasingly utilized anti-reflux surgical therapy for GERD. While the use of MSA is listed as a precaution by the United States Food and Drug Administration, there are limited data showing effective BE regression with MSA. MSA offers several advantages in BE including effective reflux control, anti-reflux barrier restoration and reduced hiatal hernia recurrence. However, careful patient selection for MSA is necessary.

Original languageEnglish (US)
Article numberdoac096
JournalDiseases of the Esophagus
StatePublished - Jun 1 2023


  • Barrett's esophagus
  • LINX
  • anti-reflux surgery
  • endoscopic eradication therapy
  • magnetic sphincter augmentation

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Magnetic sphincter augmentation: considerations for use in Barrett's esophagus'. Together they form a unique fingerprint.

Cite this